Your browser doesn't support javascript.
loading
Enhancing COVID Rehabilitation with Technology (ECORT): protocol for an open-label, single-site randomized controlled trial evaluating the effectiveness of electronic case management for individuals with persistent COVID-19 symptoms.
Hatcher, Simon; Werier, Joel; Edgar, Nicole E; Booth, James; Cameron, D William J; Corrales-Medina, Vicente; Corsi, Daniel; Cowan, Juthaporn; Giguère, Pierre; Kaluzienski, Mark; Marshall, Shawn; Mestre, Tiago; Mulligan, Bryce; Orpana, Heather; Pontefract, Amanda; Stafford, Darlene; Thavorn, Kednapa; Trudel, Guy.
Afiliação
  • Hatcher S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada. shatcher@toh.ca.
  • Werier J; Department of Psychiatry, University of Ottawa, 5457-1145 Carling Avenue, Ottawa, ON, Canada. shatcher@toh.ca.
  • Edgar NE; Department of Mental Health, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, Canada. shatcher@toh.ca.
  • Booth J; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Cameron DWJ; Department of Surgery, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, Canada.
  • Corrales-Medina V; Ontario Workers Network, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, Canada.
  • Corsi D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Cowan J; , Ottawa, Canada.
  • Giguère P; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Kaluzienski M; Division of Infectious Diseases, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada.
  • Marshall S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Mestre T; School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, Canada.
  • Mulligan B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Orpana H; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada.
  • Pontefract A; Centre of Infection, Immunity, and Inflammation, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada.
  • Stafford D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1919 Riverside Drive, Suite 406, Ottawa, ON, Canada.
  • Thavorn K; Department of Pharmacy, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, Canada.
  • Trudel G; School of Pharmaceutical Sciences, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada.
Trials ; 23(1): 728, 2022 Sep 02.
Article em En | MEDLINE | ID: mdl-36056372
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Trials Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Trials Ano de publicação: 2022 Tipo de documento: Article